Contract for the Provision of Clinical Trials Services to the LOCI Trial Manufacture (package, label) and Distribute Investigational Medical Product (IMP) including Placebo to the University of Birmingham (Campaign 3)
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £84,704 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 11 Feb 2022 |
| Contract start | 6 May 2022 |
| Contract end | 31 Dec 2023 |
| Procedure | selective |
| SME suitable | Yes |
| OCID | ocds-b5fd17-0e0bcb41-3ed0-468f-8f42-f799d1fc7f98 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| MODEPHARMA LIMITED | £84,704 | 5 May 2022 | active |
description
Contract for the Provision of Clinical Trials Services to the LOCI Trial
Manufacture (package, label) and Distribute Investigational Medical Product (IMP) including Placebo to the University of Birmingham (Campaign 3).
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 9 May 2022 | Award (award) | · | 302761bf-b3ab-462e-a998-bb97beb72a3e-535786 |
more from THE UNIVERSITY OF BIRMINGHAM
- Aston Webb Student Precinct - West Phase - QS & PD · £467,559 · 19 Feb 2025
- Life + Health Sciences Cluster - QS & PD · £504,792 · 19 Feb 2025
- HWB NMR - Main Contractor · £718,832 · 19 Feb 2025
- Aston Webb Student Precinct - West Phase - M&E · £944,642 · 19 Feb 2025
- Life + Health Sciences Cluster - M&E · £1,143,785 · 19 Feb 2025
- Provision of Technical Services at The High Temperature Research Centre (HTRC) · £3,280,000 · 19 Feb 2025
- Life + Health Sciences Cluster - Multi D · £3,293,460 · 19 Feb 2025
- IBR Chiller Replacement - M&E · £63,600 · 20 Jan 2025
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.